U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H42NO5.Na
Molecular Weight 471.6051
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM GLYCODEOXYCHOLATE

SMILES

[Na+].C[C@H](CCC(=O)NCC([O-])=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

InChI

InChIKey=VMSNAUAEKXEYGP-YEUHZSMFSA-M
InChI=1S/C26H43NO5.Na/c1-15(4-9-23(30)27-14-24(31)32)19-7-8-20-18-6-5-16-12-17(28)10-11-25(16,2)21(18)13-22(29)26(19,20)3;/h15-22,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32);/q;+1/p-1/t15-,16-,17-,18+,19-,20+,21+,22+,25+,26-;/m1./s1

HIDE SMILES / InChI
Glycodeoxycholic acid (GDCA), a bile acid, is formed in the liver from chenodeoxycholate and glycine. GDCA was one of twenty-five plasma metabolites, which were significantly different among asthma and healthy controls. Besides, GDCA was elevated in patients with acetaminophen-induced acute liver failure (AALF) and was significantly increased in non-surviving AALF patients compared with survivors. Thus GDCA level could serve as a prognostic biomarker for AALF patients.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
1998 Jan
The mechanism of bile salt-induced hemolysis.
2001
Differential modulation of cellular death and survival pathways by conjugated bile acids.
2001
Combined use of Lactobacillus reuteri and soygerm powder as food supplement.
2001 Dec
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides.
2001 Jul 3
Acute pancreatitis and bacterial translocation.
2001 May
Penetration of meropenem and cefepim into pancreatic tissue during the course of experimental acute pancreatitis.
2002 Apr
Solubilization of drugs by physiological mixtures of bile salts.
2002 Aug
Glutathione depletion with L-buthionine-(S,R)-sulfoximine demonstrates deleterious effects in acute pancreatitis of the rat.
2002 Aug
Pancreatic capillary blood flow in an improved model of necrotizing pancreatitis in the rat.
2002 Aug
Examination of the solubilization of drugs by bile salt micelles.
2002 Aug
Effects of bile acids on dog pancreatic duct epithelial cell secretion and monolayer resistance.
2002 Nov
cAMP inhibits bile acid-induced apoptosis by blocking caspase activation and cytochrome c release.
2002 Sep
Effects of heparin in experimental models of acute pancreatitis and post-ERCP pancreatitis.
2004 Feb
Noninvasive methods to determine the critical micelle concentration of some bile acid salts.
2004 Nov 1
Effects of the celecoxib on the acute necrotizing pancreatitis in rats.
2004 Oct
Effects of melatonin on acute necrotizing pancreatitis in rats.
2004 Sep
Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis.
2005
Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes.
2005 Dec
The influence of bile salts and mixed micelles on the pharmacokinetics of quinine in rabbits.
2005 May
Effects of N-acetylcysteine on acute necrotizing pancreatitis in rats.
2005 May-Jun
Bile salts inhibit growth and induce apoptosis of human esophageal cancer cell line.
2005 Sep 7
Inhibition of MRP1-mediated efflux in human erythrocytes by mono-anionic bile salts.
2005 Sep-Oct
Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats.
2006
Improvement of impaired microcirculation and tissue oxygenation by hemodilution with hydroxyethyl starch plus cell-free hemoglobin in acute porcine pancreatitis.
2006
Structure of sodium glycodeoxycholate micellar aggregates from small-angle X-ray scattering and light-scattering techniques.
2006 Jun 29
Effect of tamoxifen and raloxifene on the conjugation of bile acids with taurine and glycine in ovariectomized rats.
2006 May-Jun
[Bile salts induce differentiation in cultured human normal esophageal mucosal epithelial cells].
2006 Sep 12
Platelet function in acute experimental pancreatitis.
2007 Apr
Complexation of tauro- and glyco-conjugated bile salts with three neutral beta-CDs studied by ACE.
2007 Oct
The farnesoid X receptor FXRalpha/NR1H4 acquired ligand specificity for bile salts late in vertebrate evolution.
2007 Sep
Design and in vitro characterization of buccoadhesive drug delivery system of insulin.
2008 Jan
Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis.
2009
P-selectin inhibition reduces severity of acute experimental pancreatitis.
2009
Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis.
2009
Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?
2009 Feb
Use of correction factors in mobility shift affinity capillary electrophoresis for weak analyte-ligand interactions.
2009 May
Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.
2010 Jun 17
Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.
2010 May
Bile acid-induced virulence gene expression of Vibrio parahaemolyticus reveals a novel therapeutic potential for bile acid sequestrants.
2010 Oct 13
Effects of pantoprazole in experimental acute pancreatitis.
2010 Oct 23
Fatty acid carboxylate- and anionic surfactant-controlled delivery systems that use mesoporous silica supports.
2010 Sep 3
Loss of organic anion transporting polypeptide 1a1 increases deoxycholic acid absorption in mice by increasing intestinal permeability.
2011 Dec
Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients.
2014 Dec
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Glycodeoxycholic acid (GDCA) can induce the increase of MDA and decrease of fluidity of hepatocyte membrane, and finally cause hepatocyte injury. In the presence of GDCA (final concentration of 250 mumol/L), the concentration of hepatocyte MDA of GDCA increased significantly (P < 0.001) and membrane fluidity decreased (P < 0.02) after culture of 1 or 4 hours. ALT was directly related to MDA and fluorescence polarization (P), r was 0.945 and 0.986, respectively.
Name Type Language
J286.892J
Preferred Name English
SODIUM GLYCODEOXYCHOLATE
Common Name English
SODIUM (((3.ALPHA.,5.BETA.,12.ALPHA.,20R)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)AMINO)ACETATE
Systematic Name English
SODIUM N-((3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)AMINOACETATE
Systematic Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,12.ALPHA.)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)-, MONOSODIUM SALT
Systematic Name English
SODIUM GLYCYLDEOXYCHOLATE
Common Name English
N-(3.ALPHA.,12.ALPHA.-DIHYDROXY-24-OXO-5.BETA.-CHOLAN-24-YL)GLYCINE SODIUM SALT
Systematic Name English
(3.ALPHA.,12.ALPHA.-DIHYDROXY-24-OXO-5.BETA.-CHOLAN-24-YLAMINO)ACETIC ACID SODIUM SALT
Systematic Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,12.ALPHA.)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)-, SODIUM SALT (1:1)
Systematic Name English
2-((4R)-4-((1S,2S,11S,16S,5R,7R,10R,14R,15R)-5,16-DIHYDROXY-2,15-DIMETHYLTETRA CYCLO(8.7.0.0(2,7).0(11,15))HEPTADEC-14-YL)PENTANOYLAMINO)ACETIC ACID, SODIUM SALT
Systematic Name English
GLYCODEOXYCHOLIC ACID, SODIUM SALT
Common Name English
N-((3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXY-24-OXOCHOLAN-24-YL)AMINOACETATE
Systematic Name English
N-(2-OXO-2-(SODIOOXY)ETHYL)-3.ALPHA.,12.ALPHA.-DIHYDROXY-5.BETA.-CHOLANE-24-AMIDE
Systematic Name English
SODIUM 2-(((4R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-DIHYDROXY-10,13-DIMETHYL-2,3,4,5,6,7,8,9,11,12,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)PENTANOYL)AMINO)ACETATE
Systematic Name English
3.ALPHA.,12.ALPHA.-DIHYDROXY-24-(((SODIOOXYCARBONYL)METHYL)AMINO)-5.BETA.-CHOLAN-24-ONE
Systematic Name English
GLYCINE, N-(3.ALPHA.,12.ALPHA.-DIHYDROXY-5.BETA.-CHOLAN-24-OYL)-, MONOSODIUM SALT
Systematic Name English
Code System Code Type Description
FDA UNII
6W76V75MT1
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
CAS
16409-34-0
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
ECHA (EC/EINECS)
240-455-4
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
PUBCHEM
23688465
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY
EPA CompTox
DTXSID30936904
Created by admin on Mon Mar 31 22:15:47 GMT 2025 , Edited by admin on Mon Mar 31 22:15:47 GMT 2025
PRIMARY